| 摘要 |
Methods for diagnosing prostate cancer and lung cancer are disclosed. The methods include obtaining a biological sample from a subject, determining a level of serum secretory phospholipase A2-IIA in the biological sample, comparing the level of serum secretory phospholipase A2-IIA with a baseline level of serum secretory phospholipase A2-IIA, and diagnosing prostate cancer or lung cancer in the subject. An elevated level of serum secretory phospholipase A2-IIA as compared to the baseline level correlates to a positive diagnosis of prostate cancer or lung cancer in the subject.
|
